CD8A and neoplasm: By inhibiting VEGF and PGE2 with ASA and an anti-VEGF blocking antibody, respectively, the tumor endothelial FasL expression was attenuated and that facilitated a substantial infiltration of tumor-suppressing CD8+ TILs in the ID8 OC tumor model19.